Abstract
First, the Jenkins Activity Survey (JAS) was administered to 150 healthy subjects and 127 psychosomatic patients. Next, the responsivity of the dopaminergic system of the hypothalamo-pituitary gland was measured in 81 of these psychosomatic patients by examining the effect of bromocriptine on plasma growth hormone levels. Subjects were classified as either responders or nonresponders based on their secretion patterns. Multidimensional scaling techniques successfully discriminated between healthy subjects, psychosomatic responders and psychosomatic nonresponders using the items of the JAS. Implications for treating nonresponder psychosomatics in Japan are discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
